Sarepta Therapeutics, Inc.
Peptide Oligonucleotide Conjugates
Last updated:
Abstract:
Provided herein are oligonucleotides, peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject oligonucleotides, peptides, and peptide-oligonucleotide-conjugates described herein.
Status:
Application
Type:
Utility
Filling date:
16 Aug 2021
Issue date:
10 Mar 2022